I’ve kicked off 2023 by looking at which shares I’d like to add to my Stocks and Shares ISA. Today, I’m focused on large-cap FTSE 100 shares.
I’ve always admired fashion retailer Next (LSE:NXT). I reckon it’s the best managed clothing retailer in the UK. I’ve been expecting most retailers to report weak sales, given the cost-of-living crisis.
In contrast, Next lifted its profit outlook on Thursday and reported strong sales over Christmas. It looks like cold weather prompted many to buy coats and other winter items.
Quality business
Higher costs last year put pressure on many retailers’ profit margins. So it was good to see Next talking of lower shipping and raw material costs.
That said, it remained cautious in its outlook for the coming year. That’s no surprise as rising mortgage costs and other inflationary pressures could put further dent household finances.
Overall though, Next is a high-quality business. Its return on capital employed and profit margins are in double digits. It also offers a 3% dividend yield.
I’d consider it a good long-term holding and I’d certainly buy it if I had spare funds.
FTSE 100 bargain
The next FTSE 100 share that I’d buy is discount retailer B&M European Value Retail (LSE:BME). Like Next, it also reported strong Christmas trading yesterday. In the 13 weeks leading up to Christmas, sales rose by 12% compared to the prior year.
It reported “very good performance across all B&M UK categories, both in grocery and general merchandise”. That sounds reassuring to me.
I reckon this stock will prove resilient this year, especially if households tighten their belts.
Another feature I like about this business is that it’s still growing. With a price-to-earnings ratio of 12, it’s also reasonably priced.
To top it off, it has a dividend yield of 4%. That’s around the average for the FTSE 100. But I’d note that this could rise to a juicy 8% yield when factoring in special dividends.
There’s always the risk of competition taking a chunk out of its business though. Many UK retailers could offer similar products at similar prices.
But overall, it looks good to me right now. If I had some extra cash, I’d buy these shares today.
The best medicine
Another defensive FTSE 100 share that I’d buy right now is pharmaceutical giant Astrazeneca (LSE:AZN). It earned £3bn from Covid vaccine sales in 2021. But that’s not why I’m keen on this stock.
Cancer treatment is its main area of focus and is likely to fuel earnings growth over the coming years.
Astrazeneca’s focus on research and development (R&D) is paying dividends. It has been allocating an industry-leading 23% of its sales to its R&D budget.
That’s resulting in ample regulatory approvals and a strong pipeline of new drugs.
With a market capitalisation of over £180bn, it’s now the most valuable company in the FTSE 100. After a strong run up in its share price, is the upside limited?
It’s certainly a risk. It’s also not the cheapest stock among the Footsie giants. That said, I’m a long-term investor. And this business has years of potential growth ahead, in my opinion. As soon as I have some spare cash in my ISA, buying this share will be a ‘no-brainer’ decision for me.
The post 3 ‘no-brainer’ FTSE 100 shares I’d buy for 2023 appeared first on The Motley Fool UK.
Is AstraZeneca a top choice for growing wealth now?
Before deciding, we think this pick is another must-see.
Discover ‘One Top Growth Stock from The Motley Fool’ absolutely FREE.
Last year, this extraordinary company grew revenues by more than £217 million. And for 5 years, revenues have grown at a compounded rate of nearly 60%. That’s more-than double Google and Amazon! Earnings have exploded 3,000%.
And it’s happening in an unusual way most people never see.
As The Financial Times reports:
“On an average day, redacted readers buy roughly 43,500 items – from luxury dog beds to remote-controlled golf trolleys – after clicking on links in articles.”
When they do, this company collects some of the cash – adding up to humongous profits. Its global audience reaches some 506 million people – across 250 coveted online brands. While past performance doesn’t guarantee future results, we think the outlook could be spectacular.
So please, don’t leave without seeing, ‘One Top Growth Stock from The Motley Fool’.
Claim your FREE report now
setButtonColorDefaults(“#5FA85D”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43A24A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#FFFFFF”, ‘color’, ‘#FFFFFF’);
})()
More reading
Next shares jump 7% today. Should this be my first buy of 2023?
Revealed! The most sold FTSE 100 stocks by Hargreaves Lansdown investors
3 FTSE 100 stocks I’m watching like a hawk in January
2023 dividend forecasts: Unilever, Persimmon & Next
3 cheap FTSE 100 shares I’d buy to own for a decade or more!
Harshil Patel has no position in any of the shares mentioned. The Motley Fool UK has recommended B&M European Value. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.